PubMed Trending Research Digest — August 01, 2026

Automated digest · 98 articles · 15 research areas · August 01, 2026

Overview

Across this week’s PubMed highlights, a dominant theme is precision control—at the molecular, cellular, and clinical-decision levels. Several mechanistic studies explain how biological systems switch between states: retron antiphage defenses balance dormancy and activation; lysosomes act as a hub linking aging to lysosomal storage disease signatures; and nutrient/metal/translation pathways (e.g., arginine restriction, V-ATPase–autophagy–Notch crosstalk, heme-sensing via CLPX–CLPP) tune immune surveillance, stem-cell fate, or metabolic remodeling. In parallel, genetics and biomarkers are increasingly used to narrow risk: GWAS work identifies shared or disease-specific gene architectures (myopia–exotropia; inherited retinal dystrophy), while proteomic and CSF synaptic signatures aim to forecast disease onset or stratify psychiatric and neurodegenerative biology.

A second major thread is targeted therapy development and optimization in oncology and immune-mediated disease. Trials and translational studies span from novel immunotherapies (GPC3 TCR fusion; PARP inhibitor plus pembrolizumab via STING rationale; dual checkpoint blockade in breast cancer) to strategies for overcoming resistance and preventing metastatic escape (PHGDH–H3K27me3 immune-scarce niches; DNMT3B-driven neuroendocrine plasticity; chemotherapy-induced SASP metabolic programs that promote dissemination). Evidence synthesis and consensus efforts also reflect a push toward decision frameworks when head-to-head data are limited—network meta-analyses for SSc-ILD and hypertension, and Delphi consensus for non-metastatic NSCLC management.

Finally, multiple studies emphasize practical clinical translation: perioperative and real-world evidence (dapagliflozin for post-surgical AKI; PPI effects on dasatinib switching; fluid-balance timing in sepsis-associated AKI), guideline updates (kidney stone prevention; ACLF critical care), and patient-centered or scalable interventions (mindfulness-based cognitive therapy for NSSI; VR-based psychotherapy for depression; community-driven advocacy for ketogenic diet trials in schizophrenia). Together, these papers show a field moving from “what works” toward “for whom, when, and through what mechanism,” with biomarkers, imaging, and mechanistic biology increasingly guiding that transition.

---

Bacterial defense systems & microbial genetics

The genomic identity of early smallpox in South America.

This study reconstructed ancient smallpox genomes from two Inca-Colonial individuals in northern Chile to determine the genomic identity and timing of early smallpox in South America. The genomes belonged to an extinct lineage diverging around 1296 CE and provided molecular evidence that smallpox was introduced through European colonization, with a constant tempo of gene inactivation until the late 16th century. The findings are significant for historical epidemiology and for understanding variola evolution by anchoring lineage relationships to dated ancient DNA.

Romero González B, Reyes-Madrid M, Arriaza B et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗

Supergene control of chiral development in mirror-image flowers.

This study investigated how genetic control and gravitropism shape left–right (chiral) placement of female and male organs in butterfly lilies (mirror-image flowers). The authors identified a hemizygous supergene containing two candidate causal loci, MIR156-R and YUCCA-R, that coordinately drives opposite orientation of female versus male organs relative to an external reference axis. These findings establish a mechanistic genetic basis for floral chirality and suggest supergenes can coordinate complex organ-level asymmetry to optimize cross-pollination.

Xue H, Saltini M, Illing N et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗ · Free PDF ↗

X-chromosome inactivation draws L1 mutagenesis to the human X chromosome.

This study examined whether X-chromosome inactivation (XCI) influences the genomic targeting of LINE-1 (L1) retrotransposons in the human PA-1 embryonic carcinoma cell line. Using long-read, haplotype-aware analysis of engineered L1 integration, the authors found that clonal XCI enabled separation of active (Xa) and inactive (Xi) X haplotypes and that L1 strongly favored Xi and other late-S-phase replication regions. The results support the idea that the human X chromosome is L1-rich because of XCI-associated chromatin and replication timing, linking epigenetic state to retrotransposon landscape.

de Los Rios Barreda J, Ferreiro ME, Jansz N et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗

Enabling sustainable supply of the essential cancer medicines etoposide and teniposide in yeast.

This study engineered yeast to biosynthesize podophyllotoxin-type aryltetralin lignan precursors that can be converted into the anticancer drugs etoposide and teniposide. By identifying key glycosyltransferases and performing more than 60 genetic edits involving 45 heterologous enzymes, the authors enabled a sustainable production route from engineered yeast rather than extraction from the endangered plant Sinopodophyllum hexandrum. This work provides a scalable biomanufacturing platform for essential cancer medicines and reduces reliance on threatened natural sources.

Shen S, Hu X, Li D et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗

An orally available PfPKG inhibitor blocks Plasmodium’s infection of the liver.

This study characterized RUPB-61, the first orally bioavailable inhibitor of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG), and tested its ability to block liver-stage infection. RUPB-61 prevented infection by P. falciparum and P. cynomolgi sporozoites, including hypnozoite formation by P. cynomolgi, and a single oral dose blocked liver infection by P. berghei sporozoites in vivo with efficacy consistent with once-weekly prophylaxis. These findings support PfPKG inhibition as a promising strategy for oral malaria chemoprevention targeting the liver stage.

Dhiyebi H, Mbaye A, Thaniana A et al. · PLoS pathogens · (2026) · View on PubMed ↗

Dual-inhibitory mechanism of the bacterial retron Ec78 antiphage defense system.

The study investigated how the bacterial retron Ec78 antiphage defense system regulates its PtuAB effector complex in bacteria. It found a dual-inhibitory mechanism in which ATP/ADP binding to the PtuAB nucleotide-binding domain drives assembly of an inactive tetrameric complex, while the RT-msDNA antitoxin stabilizes an inhibited Ec78 conformation and stimulates ATP turnover to prime rapid activation. This mechanistic insight clarifies how retron effectors are tightly controlled to balance dormancy and emergency phage defense, informing broader principles of prokaryotic abortive infection systems.

Lin Z, Guo M, Lu Z et al. · Proceedings of the National Academy of Sciences of the United States of America · (2026) · View on PubMed ↗

O-GlcNAc clusters in intrinsically disordered regions regulate transcriptional condensates and gene control.

The research examined how O-linked β-N-acetylglucosamine (O-GlcNAc) modifications in intrinsically disordered regions (IDRs) regulate transcriptional liquid-liquid phase separation (LLPS) and gene control, with Bromodomain-containing protein 4 (BRD4) as a key example. Clustered O-GlcNAc sites enriched in transcription-related IDRs—especially 12 clustered sites in the BRD4 C-terminal IDR—reduced condensate size while increasing condensate dynamics, thereby modulating transcriptional condensates. This mechanistic link between O-GlcNAc clustering and LLPS regulation advances understanding of how PTM “codes” control gene expression.

Shao G, Deng Q, Wang T et al. · Protein & cell · (2026) · View on PubMed ↗ · Free PDF ↗

---

Reproductive aging, gametogenesis & fertility

TRIM37 interacts with TRIM28 to maintain primordial germ cell identity during migration.

This Cell Research study investigated how the E3 ubiquitin ligase TRIM37 maintains primordial germ cell (PGC) identity during embryonic migration. It found that Trim37 deficiency causes severe PGC defects starting at E9.5 with complete PGC depletion by E12.5 and an aberrant transition toward somatic cell states, mediated by TRIM37 binding TRIM28 via its MATH domain and ubiquitinating TRIM28 via its RING domain to enhance TRIM37–TRIM28 interaction and nuclear retention. The work is significant because it identifies a molecular safeguard mechanism that preserves germline fate after specification.

Li Q, Yin X, Li C et al. · Cell research · (2026) · View on PubMed ↗

Metformin added to lifestyle intervention for physical function in older adults with obesity (DEMFOS trial): a randomised controlled trial.

The DEMFOS trial randomized older adults with obesity to intensive lifestyle intervention plus metformin versus lifestyle intervention plus placebo to test whether metformin improves physical function. The key finding was that adding metformin to lifestyle did (or did not, per the trial results) enhance physical-function outcomes in this frailty-risk population. If beneficial, this would support metformin as an adjunct to lifestyle for preserving mobility and reducing disability risk in older adults with obesity.

Nava MLD, Viola V, Aguilar M et al. · The lancet. Healthy longevity · (2027) · View on PubMed ↗

A new era of integration of genetics and neurology.

This review synthesized recent advances in pediatric neurology emphasizing how next-generation sequencing (exome/genome sequencing) is integrated into clinical evaluation and how neurogenomics enables precision, disease-specific therapies. It highlights that broad genetic testing is increasingly central to diagnosis and risk stratification, shifting care from primarily symptomatic management toward targeted approaches. The review’s significance is to guide clinicians and researchers on implementing genomic diagnostics and translating neurogenomic findings into pediatric precision medicine.

Sen K, Gropman A, Ensert Cihan C et al. · Current opinion in pediatrics · (2026) · View on PubMed ↗

From manual counting to YOLO: Using computer vision to automate large-scale fecundity assays in C. elegans.

This study developed and validated computer-vision automation to measure fecundity in the nematode Caenorhabditis elegans, replacing manual counting of offspring. Using YOLO-based analysis on 9,972 brood images from individual hermaphrodites, the authors aimed to increase throughput and reduce human counting error. The approach enables large-scale, higher-precision reproductive phenotyping for genetic and environmental studies in C. elegans.

Peng L, Shui H, Janisch AN et al. · PloS one · (2026) · View on PubMed ↗

Insufficiency of cohesin regulatory protein PDS5B triggers meiotic failure and aneuploidy in oocytes during advanced maternal aging.

The study examined whether age-related insufficiency of the cohesin regulatory protein PDS5B causes meiotic failure and aneuploidy in human oocytes during advanced maternal aging. It found that PDS5B declines with age and localizes to spindle poles during oocyte meiosis, where it supports spindle pole formation through a noncanonical function independent of its canonical cohesion role. These findings link PDS5B loss to reproductive aging–associated chromosomal missegregation, highlighting a potential molecular target for improving oocyte quality.

Zhang Y, Bai J, Li N et al. · Proceedings of the National Academy of Sciences of the United States of America · (2026) · View on PubMed ↗

Bazi Bushen Capsule restores fertility by targeting mitochondrial health in aging endometrium.

This study investigated whether Bazi Bushen Capsule (BZBS) restores fertility in aging endometrium by targeting mitochondrial health, using naturally aged mice and d-galactose-induced senescent human endometrial stromal cells plus primary human endometrial stromal cells. BZBS improved endometrial receptivity and decidualization by activating the AMPK–SIRT3 pathway, supported by single-cell RNA sequencing, transcriptome analysis, network pharmacology, and molecular dynamics simulations. These findings suggest a mitochondria-focused mechanism for BZBS in reversing endometrial aging phenotypes, offering a potential therapeutic route to improve fertility in age-related endometrial dysfunction.

Li S, Deng F, Niu H et al. · iMeta · (2026) · View on PubMed ↗ · Free PDF ↗

---

CAR T-cell toxicity management (ICANS) & neuroinflammation

The effect of mindfulness-based cognitive therapy on non-suicidal self-injury in hospitalized adolescents with depressive disorders: a randomized controlled trial.

This randomized, single-blind controlled trial tested mindfulness-based cognitive therapy for adolescents (MBCT-A) plus treatment-as-usual (TAU) versus TAU alone for non-suicidal self-injury (NSSI) in 94 hospitalized adolescents with depressive disorders. The key finding was that MBCT-A reduced NSSI severity compared with TAU alone. This supports MBCT-A as a feasible adjunctive intervention to target self-injury risk in depressed hospitalized adolescents.

Xie J, Li L, Liu X et al. · Psychological medicine · (2026) · View on PubMed ↗

The liver-secreted protein FGL1 restrains a subset of innate-like B cell responses via the receptor TACI.

This Immunity study tested whether the liver-secreted immune regulator FGL1 restrains innate-like B cell responses through receptors beyond LAG3 by using recombinant FGL1 in lupus-like B6/lpr mice and receptor identification via genome-wide surface proteome screening. The key finding was that FGL1 reduced autoimmune symptoms by diminishing antigen-specific IgM responses and B cell numbers, with TACI (a TNFR-family receptor) implicated as the relevant receptor for this B cell regulation. Clinically, it suggests a potential therapeutic pathway to modulate pathogenic B cell activity in autoimmune disease via FGL1–TACI signaling.

Su TT, He J, Wang Y et al. · Immunity · (2026) · View on PubMed ↗

Early neurologic response predicts outcomes after anakinra for immune effector cell-associated neurotoxicity syndrome.

The study evaluated whether early neurologic response predicts outcomes after anakinra treatment for immune effector cell-associated neurotoxicity syndrome (ICANS) in 101 patients receiving CAR T-cell therapy. It reported a median 8-day time to ICANS resolution with 28-day cumulative ICANS resolution of 86% and treatment-related mortality of 13%, with 28% experiencing anakinra failure. Clinically, early neurologic response can help stratify patients likely to benefit from anakinra versus those at higher risk of persistent ICANS or death.

Liang EC, Kungwankiattichai S, Wu X et al. · Blood advances · (2026) · View on PubMed ↗ · Free PDF ↗

International advocacy for ketogenic diet research in schizophrenia: insights from a public petition.

This study analyzed an international Change.org public petition to advocate for resuming a halted randomized blinded inpatient trial of a ketogenic diet in people with schizophrenia, using quantitative petition metrics and qualitative comment analysis. The key finding was that the petition garnered 21,637 signatures and 1,105 comments across 151 countries, with themes extracted using top-down consensus coding and topic modeling via Latent Dirichlet Allocation (LDA). The scientific significance is that it documents global patient/community demand and perceived unmet needs to help justify and accelerate renewed clinical research into ketogenic diet interventions for schizophrenia.

Murray SL, Roche DJO, Palmer CM et al. · Frontiers in public health · (2026) · View on PubMed ↗ · Free PDF ↗

---

Early-life microbiome & atopic disease prevention

Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset.

This study examined whether a plasma proteomics signature can predict future metabolic dysfunction-associated steatotic liver disease (MASLD) in humans, using discovery and validation across more than 50,000 participants from multiple cohorts (Southern UK, Northern UK, EPIC-Norfolk, and Southern China). It identified and validated a five-protein panel—FUOM, ACY1, KRT18, CDHR2, and GGT1—that predicts incident MASLD with reported AUC performance up to ~16 years. The significance lies in enabling long-term risk stratification for MASLD using minimally invasive blood-based biomarkers before clinical onset.

Yu S, Chen C, Feng J et al. · Nature aging · (2026) · View on PubMed ↗

Platelet-derived serotonin epigenetically programs macrophage alternative activation to orchestrate type 2 airway inflammation.

The study investigated how platelet-derived serotonin epigenetically programs macrophage alternative activation to orchestrate type 2 airway inflammation, using single-cell transcriptomics of human nasal polyps from eosinophilic chronic rhinosinusitis (eCRS) patients with or without comorbid asthma and dust mite–induced mouse models. It identified a TGM2hi macrophage population enriched in inflamed human tissues that correlated with eosinophilia and disease burden, and showed in mice that platelet-derived serotonin drives macrophage alternative activation via epigenetic reprogramming to shape type 2 inflammation. These findings link coagulation/platelet recruitment to macrophage epigenetic control of T2 airway disease, suggesting serotonin–macrophage pathways as potential therapeutic targets.

Tang R, Xia G, Zhu Y et al. · Cellular & molecular immunology · (2026) · View on PubMed ↗

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

In a 36-week multicentre, randomized, parallel, double-blind, placebo-controlled phase 2 trial, adults with type 2 diabetes (HbA1c 7.0–10.0%) were assigned to once-weekly subcutaneous zenagamtide (a unimolecular GLP-1/amylin receptor agonist) at different doses or placebo. The study’s dose-finding results showed a dose-response relationship for efficacy with an associated safety profile versus placebo. Clinically, these data support the potential of weekly zenagamtide as a next-generation incretin/amylin-based therapy for type 2 diabetes.

Mora P, Aroda VR, Asong M et al. · Lancet (London, England) · (2026) · View on PubMed ↗

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

In a 36-week multicentre, randomized, parallel, double-blind, placebo-controlled phase 2 trial, adults with type 2 diabetes (HbA1c 7.0–10.0%) were assigned to once-daily oral zenagamtide (a unimolecular GLP-1/amylin receptor agonist) at different doses or placebo. The key finding was a dose-response effect on glycaemic efficacy with tolerability outcomes compared with placebo. This is significant because it evaluates whether oral zenagamtide can deliver GLP-1/amylin receptor–mediated benefits with acceptable safety in a broad international outpatient population.

Mora P, Aroda VR, Asong M et al. · Lancet (London, England) · (2026) · View on PubMed ↗

Poricoic acid a ameliorates ulcerative colitis via AMPK/PPARγ pathway-dependent cellular senescence inhibition and concomitant gut microbiota-metabolome modulation.

This study tested poricoic acid A (PAA) in a DSS-induced murine model of ulcerative colitis (UC) and in intestinal epithelial cells, focusing on AMPK/PPARγ signaling, cellular senescence, and gut microbiota–metabolome changes. PAA ameliorated UC and DSS-driven senescence in intestinal epithelial cells via an AMPK/PPARγ pathway–dependent inhibition of cellular senescence, accompanied by coordinated modulation of gut microbiota and metabolite profiles. The results support PAA as a multi-target candidate that links inflammatory bowel disease, senescence biology, and microbiome-metabolome remodeling.

Wang Y, Liu Z, Hou Q et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · (2026) · View on PubMed ↗

Efficacy of probiotics in preventing atopic dermatitis in infants: A systematic review and meta-analysis.

The study systematically reviewed randomized controlled trials to test whether probiotic supplementation in infants aged 0–36 months prevents atopic dermatitis. It found that evidence across trials was inconsistent, and the meta-analysis aimed to quantify whether probiotics reduce atopic dermatitis risk compared with placebo or no intervention. If supported by the pooled results, this would inform early-life microbiome interventions as a preventive strategy for atopic dermatitis.

Wei T, Ding Y · The Journal of international medical research · (2026) · View on PubMed ↗ · Free PDF ↗

Oral LNAD+ rapidly elevates whole blood intracellular NAD and metabolic flux without elevating plasma NAD: evidence from a randomized controlled trial.

This randomized, double-blind, placebo-controlled Phase 0/1b trial evaluated the NAD+ precursor strategy using oral LathMized® NAD+ (LNAD+) in healthy adults aged 45–75 years (RENEWAL-NAD+, NCT07336836). The key finding was that 5 days of oral LNAD+ rapidly increased whole-blood intracellular NAD and metabolic flux without elevating plasma NAD. Scientifically, it suggests a formulation/route that bypasses bottlenecks seen with systemic NAD+ precursor approaches, supporting further development of NAD+ boosting interventions for aging- and disease-related metabolic stress.

Kornilov SA, Hastings WJ, McGrath LF et al. · GeroScience · (2026) · View on PubMed ↗ · Free PDF ↗

Efficacy and Safety of Bimagrumab in Adults With Obesity and Metabolic Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

This systematic review and meta-analysis evaluated the efficacy and safety of bimagrumab in adults with obesity and metabolic dysfunction, drawing on randomized controlled trials in populations including insulin resistance and type 2 diabetes mellitus (T2DM). Across included RCTs, the analysis synthesized effects on body composition and glucose-related outcomes while assessing safety and risk of bias using Cochrane RoB 2 and grading evidence with GRADE. The findings aim to clarify whether bimagrumab provides clinically meaningful metabolic and compositional benefits with an acceptable safety profile in these patient groups.

Shao C, Lin H, Yu J et al. · Diabetes, obesity & metabolism · (2026) · View on PubMed ↗

Efficacy and Safety of Dual and Triple Glucagon-Like Peptide-1-Based Polyagonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Meta-Analysis.

This systematic review and meta-analysis evaluated randomized controlled trials in adults with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) comparing dual or triple GLP-1-based polyagonists versus placebo. The key finding was the overall efficacy and safety profile of these GLP-1 polyagonist regimens across MASLD/MASH outcomes, synthesized from the included RCT evidence. Clinically, it informs whether dual/triple GLP-1 polyagonists provide meaningful therapeutic benefit for steatotic and inflammatory liver disease beyond placebo, supporting evidence-based selection of metabolic–hepatic combination therapies.

Santos Solis R, Baeza-Zapata AA, Negrete-Najar JP · Cureus · (2026) · View on PubMed ↗ · Free PDF ↗

---

Genetics of inherited retinal dystrophies

Therapeutic Time Window of Disease-Modifying Therapy for Early Alzheimer’s Disease in Japanese Individuals: Analysis Based on J-ADNI Study.

This retrospective analysis of the J-ADNI cohort evaluated the “therapeutic time window” for disease-modifying therapy eligibility in Japanese patients with early Alzheimer’s disease who were amyloid-positive and would otherwise meet lecanemab or donanemab criteria. The study examined how long patients remained eligible and which baseline factors (including MMSE and CDR-GS) predicted window duration in an Asian population. The findings address generalizability of North American eligibility predictors and help clinicians time initiation of anti-amyloid DMTs in Japanese patients.

Nakashima S, Sato K, Niimi Y et al. · Geriatrics & gerontology international · (2026) · View on PubMed ↗

The molecular architecture of mammalian vitreous body collagen fibrils.

This study determined the high-resolution molecular architecture of native mammalian vitreous body collagen fibrils from porcine tissue using tailored long-period filament cryo-electron microscopy processing. It resolved a 67-nm periodic unit containing type II, V/XI, and IX collagen triple helices plus opticin at a stoichiometry of 8:4:4:4, and identified detailed higher-order packing including galactose–glucose disaccharide modifications on conserved hydroxylysine residues. The structural insights are significant for understanding extracellular matrix organization and for informing diseases affecting ocular vitreous collagen.

Lou X, Cong Y, Xu Y et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗

PM-DUnet: Fusing long-range dependencies and attention in a dual-U architecture for thyroid nodule segmentation.

This paper studied thyroid nodule segmentation using a new deep-learning architecture, PM-DUnet, designed to capture both local details and long-range dependencies. The authors introduced a dual-U-Net coarse-to-fine refinement framework and a Multi-Path Parallel Mamba (MPM) module based on state space models (SSMs) to model global context with linear complexity. This scientific contribution is a more context-aware segmentation method that may improve accuracy on nodules with variable sizes and ambiguous boundaries.

Wang S, Zhang L, Shi G et al. · PloS one · (2026) · View on PubMed ↗

XXYLT1 and Mendelian Retinal Dystrophy.

The study used a genome-wide association study (GWAS) approach with replication in two inherited retinal disease (IRD) cohorts to identify genes underlying Mendelian retinal dystrophy, focusing on XXYLT1. It leveraged large-scale genomic resources (FinnGen, the 100,000 Genomes Project, and NHS Genomic Medicine Service cohorts) and applied GWAS plus replication to nominate XXYLT1 as an IRD-associated gene. This provides a gene-level candidate for diagnosis and future functional validation in rare inherited retinal dystrophies.

Kraatari-Tiri M, Ishtiaq H, Tyrmi J et al. · JAMA ophthalmology · (2026) · View on PubMed ↗

---

Hepatocellular carcinoma (HCC) interventional therapy

Creating true and false memories from forgotten information in Drosophila.

This Drosophila study investigated how reminder cues reactivate forgotten aversive memories and how true versus false memory formation can be controlled in the mushroom body circuitry. It found that forgotten memories persist as silent traces in mushroom body output neurons and that reminders reinstate the original trace to recover memory expression, while manipulating reminders can distort recovery and promote false memories. The work is significant because it identifies a mechanistic neural substrate for memory reactivation and provides a tractable model for understanding how targeted memory retrieval can go wrong.

Yang W, Zattera B, Pavão-Delgado M et al. · Nature neuroscience · (2026) · View on PubMed ↗

The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming.

This Nature Aging study investigated how chemotherapy-induced senescence-associated secretome (SASP) drives metastatic dissemination in high-grade serous ovarian cancer (HGSOC), focusing on cisplatin-induced SASP. It found that the cisplatin SASP promotes cell detachment and in vivo dissemination via a fructose-containing metabolic component, with complex I identified as the driver of SASP-mediated effects and a high-fructose diet increasing HGSOC dissemination. The findings are significant because they link a specific SASP metabolic program to metastasis and suggest potential metabolic targets to mitigate chemotherapy-associated spread.

Cole AR, Buj R, Uboveja A et al. · Nature aging · (2026) · View on PubMed ↗

Activating RARβ to overcome immunomodulatory drug resistance in t(4;14) human myeloma.

This work studied whether activating retinoic acid receptor beta (RARβ) can overcome immunomodulatory drug (IMiD) resistance in t(4;14) multiple myeloma (MM), using a high-throughput screen of 1855 FDA-approved pharmaceuticals and mechanistic assays in t(4;14) MM cells. All-trans retinoic acid (ATRA) alone was not anti-MM but potently enhanced IMiD cytotoxicity by activating RARβ, which bound retinoic acid response elements in the FGFR3 promoter to increase FGFR3 transcriptional regulation and sensitize cells to IMiDs. The results support RARβ activation with ATRA as a rational combination strategy to improve outcomes in high-risk t(4;14) MM with IMiD resistance.

Zhong L, Wang Q, Xian M et al. · Leukemia · (2026) · View on PubMed ↗

Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

This article reviewed the clinical toxicity of antibody-drug conjugates (ADCs) and immune checkpoint inhibitor (ICI)–ADC combinations, focusing on mechanistic overlap and organ-specific toxicity patterns relevant to oncology practice. It concludes that despite different upstream mechanisms, ADCs and ICIs frequently converge on similar toxicities across pulmonary, hepatic, gastrointestinal, and cutaneous systems, complicating attribution and management—especially as ICI-ADC combinations move into earlier and potentially curative-intent settings. The synthesis provides a framework for clinicians to anticipate, manage, and consider rechallenge after toxicity resolution in patients receiving ICI-ADC regimens.

Peters S, Grivas P, Massard C et al. · Nature reviews. Clinical oncology · (2026) · View on PubMed ↗

Circulating biomarkers in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.

This analysis evaluated prognostic circulating protein biomarkers and the effect of nintedanib on these biomarkers in systemic sclerosis-associated interstitial lung disease (SSc-ILD) within the SENSCIS trial. Baseline serum/plasma proteins representing inflammation, epithelial dysfunction, and extracellular matrix (ECM) synthesis/turnover were assessed for association with 52-week decline in forced vital capacity (FVC) and change in modified Rodnan Skin Score (mRSS), and biomarker shifts were examined in relation to nintedanib treatment. The work aims to clarify which circulating pathways predict disease progression and how nintedanib modulates them, supporting biomarker-informed risk stratification in SSc-ILD.

Assassi S, Kuwana M, Denton CP et al. · Annals of the rheumatic diseases · (2026) · View on PubMed ↗

Effect of nerandomilast on survival in patients with pulmonary fibrosis.

This study assessed the robustness of nerandomilast’s effect on survival in patients with pulmonary fibrosis by reanalyzing data from the placebo-controlled FIBRONEER-IPF and FIBRONEER-ILD trials. Using Cox proportional hazards models for time to death (excluding deaths after lung transplant) and performing sensitivity, tipping point, and supplementary analyses around death timing, it tested whether the numerical survival signal remained consistent under alternative assumptions. The results inform how confidently nerandomilast’s potential survival benefit can be interpreted for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.

Oldham JM, Assassi S, Azuma A et al. · The European respiratory journal · (2026) · View on PubMed ↗

Therapy-Associated Lineage Plasticity in DIPG Following Combined CDK4/6 Inhibitor, Temozolomide, and Radiation.

This preclinical study investigated therapy-associated lineage plasticity in diffuse intrinsic pontine glioma (DIPG) after combined treatment with the CDK4/6 inhibitor abemaciclib, temozolomide (TMZ), and radiation (XRT), using two patient-derived orthotopic xenograft (PDOX) models (treatment-naïve biopsy IBs-9119DIPG and previously treated autopsy IBs-A0317DIPG). It evaluated treatment activity in PDOX-derived 3D tumor organoids and in randomized DIPG PDOX studies, then used survival analysis and immunohistochemistry to characterize residual cell-state plasticity after therapy. These findings help explain how DIPG cells adapt to combined CDK4/6 inhibition–based regimens, guiding strategies to prevent lineage switching and improve durability of response.

Huang Z, Jiang T, Suarez Palacios MM et al. · Cancer letters · (2026) · View on PubMed ↗

Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC.

This international multidisciplinary consensus used a modified Delphi process among 89 thoracic oncology experts to address evidence gaps in real-world management of non-metastatic non-small-cell lung cancer (NSCLC). The panel produced consensus statements to clarify major areas of uncertainty in multimodality and biomarker-driven care for non-metastatic disease. These recommendations are intended to bridge trial evidence and clinical practice and help standardize decision-making where current guidelines are insufficient.

Meyer ML, Peters S, Borghaei H et al. · Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · (2026) · View on PubMed ↗

Dietary arginine drives codon-dependent MHC class I translation and improves immunity in colon tumorigenesis and respiratory viral infection.

This Cell study investigated how dietary arginine restriction affects codon-dependent translation of MHC class I and antigen presentation during colon tumorigenesis and respiratory viral infection. The key finding was that extracellular arginine restriction represses specific arginine tRNAs, thereby suppressing translation of MHC class I in a codon-usage–dependent manner, weakening anti-viral immunity and increasing colon tumorigenesis. These results are significant because they identify a mechanistic nutrient–translation–immunity axis that could be leveraged to modulate immune surveillance in cancer and infection.

Wu Q, Seydlitz LM, Iakimov V et al. · Cell · (2026) · View on PubMed ↗

Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in patients with Advanced Hepatocellular Carcinoma.

This phase I open-label dose-escalation trial studied the safety and preliminary activity of the GPC3-targeted TCR fusion construct CT0180 in patients with advanced, GPC3-positive hepatocellular carcinoma (HCC) after progression on or intolerance to standard therapies, following fludarabine/cyclophosphamide lymphodepletion. CT0180 is designed to bind glypican-3 (GPC3) and integrate into the native T cell receptor (TCR) complex via a CD3ε-linked single-chain variable fragment to trigger full TCR signaling. If effective and tolerable, this strategy could provide a tumor-specific immunotherapy option for later-line advanced HCC with limited responses to existing treatments.

Sun X, Gao W, Shou C et al. · Clinical cancer research : an official journal of the American Association for Cancer Research · (2026) · View on PubMed ↗

Signatures of aging and disease in a single organelle.

This Science article investigated how aging and disease are reflected in lysosomal metabolites within single organelles, focusing on lysosome-associated metabolic changes. It reports that lysosomal metabolite alterations track both normal aging and lysosomal storage disease states, implying shared biochemical signatures at the organelle level. The work is significant because it supports lysosomes as a mechanistic hub connecting aging biology to lysosomal disease phenotypes and biomarkers.

Na J, Brunet A · Science (New York, N.Y.) · (2026) · View on PubMed ↗

Spatiotemporal multiomics uncover tumor ecosystem dynamics during metastatic colonization.

This Science study integrated spatiotemporal multiomics—single-cell and spatial profiling—across liver cancer mouse models and human metastases to track disseminated tumor cell (DTC) interactions during metastatic colonization. It identified a residual quiescent Phgdh^high DTC population that survived innate immune clearance, transiently enriched in micrometastases, and shaped an immune-scarce niche via PHGDH-dependent, H3K27me3-mediated epigenetic silencing. The work is significant because it links a specific metabolic-epigenetic program (PHGDH→H3K27me3) to immune evasion during metastatic seeding, suggesting actionable targets to prevent or treat metastasis.

Sun Y, Zhong Y, Liu S et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗

Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma: The Phase 3 TORCH Randomized Clinical Trial.

The study evaluated whether adding thermal ablation to transarterial chemoembolization (TACE) improves outcomes versus TACE alone in patients with liver-confined unresectable hepatocellular carcinoma (HCC) in the phase 3 TORCH randomized clinical trial. It tested the combined TACE-plus-thermal-ablation strategy in Barcelona Clinic Liver Cancer stage B patients at two tertiary centers in China. If effective, this could change standard treatment sequencing for unresectable HCC by improving survival or disease control beyond TACE alone.

Lyu N, Yi JZ, Wu XT et al. · JAMA oncology · (2026) · View on PubMed ↗

Secondary Atrial Fibrillation in Critically Ill Sepsis Patients: Evaluating the Role of Early Oral Anticoagulants in a Retrospective Multi-Center Study.

This retrospective multi-center TriNetX study examined adults with sepsis who developed new-onset atrial fibrillation (AF) within 3 days and compared early initiation of oral anticoagulants (OAC) versus no OAC. The key finding was that the net clinical benefit of early OAC in this high-risk setting remains uncertain because outcomes were evaluated using propensity score matching (1:1; 90 covariates; caliper 0.1) but the evidence base is limited and confounded by observational design. Scientifically and clinically, it highlights the need for randomized trials to determine whether early OAC reduces ischemic stroke/mortality without increasing bleeding in sepsis-associated AF.

Qadeer A, Fouad M, Bayomi D et al. · Journal of intensive care medicine · (2026) · View on PubMed ↗

Efficacy and Safety of Therapies for Systemic Sclerosis-Associated Interstitial Lung Disease: A Bayesian Network Meta-Analysis.

This Bayesian network meta-analysis compared randomized controlled trial therapies for systemic sclerosis-associated interstitial lung disease (SSc-ILD) in patients with HRCT-confirmed disease, focusing on rituximab (RTX), tocilizumab (TCZ), nintedanib (NIN), cyclophosphamide (CYC), mycophenolate (MMF), and pirfenidone. The key finding is that comparative effectiveness across these immunomodulatory and antifibrotic options remains uncertain, prompting a network synthesis to rank relative benefits and harms. The clinical significance is that it provides a framework for evidence-based selection of SSc-ILD treatments when head-to-head trial data are lacking.

Li PY, Huynh A, Yu E et al. · Annals of the American Thoracic Society · (2026) · View on PubMed ↗

Revolutionizing 2L+ Myeloma: A Podcast on the New Era of BCMA-Targeted Bispecific Antibody Therapies.

This review/podcast article discussed the evolving second-line and later (2L+) treatment landscape in multiple myeloma (MM) with emphasis on BCMA-targeted bispecific antibody therapies for patients increasingly exposed to multiple prior regimens. The key finding is that, as first-line combination regimens improve outcomes, more patients reach relapse with multi-class refractoriness, making early use of the most effective available therapy in 2L+ critical. Clinically, it frames how BCMA bispecific antibodies may be positioned to counter worsening prognosis and higher attrition across successive lines of therapy.

Mina R, Doyle M, Nooka AK · Advances in therapy · (2026) · View on PubMed ↗ · Free PDF ↗

Association between proton pump inhibitor co-medication and treatment switching in dasatinib-treated patients with chronic myeloid leukemia: a German real-world evidence study.

This German real-world evidence retrospective cohort study assessed whether proton pump inhibitor (PPI) co-medication affects treatment switching in dasatinib-treated adults with chronic myeloid leukemia (CML) using statutory health insurance claims from 2010–2024. The key finding is that, because dasatinib absorption is pH-dependent and PPIs can reduce dasatinib exposure, the study evaluated time to switch to another systemic CML therapy in incident and prevalent cohorts with propensity score matching to address confounding. Clinically, it addresses whether PPI use should be avoided or managed to preserve dasatinib effectiveness and reduce premature treatment changes.

Mueller S, Pan CC, Bosák J et al. · Annals of hematology · (2026) · View on PubMed ↗ · Free PDF ↗

[18F]FAPI-42 PET/CT for prognostic assessment in idiopathic pulmonary fibrosis: a prospective head-to-head comparison with [18F]FDG PET/CT.

This prospective head-to-head study compared prognostic performance of [18F]FAPI-42 PET/CT versus [18F]FDG PET/CT in 52 patients with idiopathic pulmonary fibrosis (IPF). The key finding was that uptake metrics from the two tracers were correlated with disease severity measures (FVC% predicted, DLCO% predicted) and GAP stage, with additional validation using immunohistochemistry for FAP and GLUT-1. Scientifically and clinically, it evaluates whether fibroblast activation imaging ([18F]FAPI-42) provides superior prognostic assessment compared with glucose metabolism imaging ([18F]FDG) in IPF.

Fang Q, Hou P, Xia S et al. · European journal of nuclear medicine and molecular imaging · (2026) · View on PubMed ↗

DNMT3B drives neuroendocrine lineage plasticity and aggressive progression in prostate cancer.

The study investigated how the de novo DNA methyltransferase DNMT3B regulates neuroendocrine lineage plasticity and aggressive progression in prostate cancer, focusing on enzalutamide-resistant prostate adenocarcinoma (EnzR-PrAd) and neuroendocrine prostate cancer (NEPC). DNMT3B was identified as a stemness-related gene upregulated in EnzR-PrAd cells and further elevated in NEPC, with DNMT3B-driven programs linked to neuroendocrine differentiation and progression. These findings suggest DNMT3B as a mechanistic driver and potential therapeutic target to overcome enzalutamide resistance and limit NEPC aggressiveness.

Jo Y, Jung H, Wang Z et al. · Molecular cancer research : MCR · (2026) · View on PubMed ↗

Efficacy of first-line treatment in driver gene-negative non-small cell lung cancer with liver metastases: a Bayesian network meta-analysis.

This Bayesian network meta-analysis compared first-line treatment regimens for driver gene-negative non-small cell lung cancer (NSCLC) with liver metastases by integrating evidence from 20 randomized controlled trials. The key finding was a comparative ranking of chemotherapy, immunotherapy, and combination strategies for survival/prognostic outcomes in this specific patient subgroup using R (4.2.3) and RevMan (5.4). Scientifically and clinically, it aims to identify the most effective first-line approach for driver gene-negative metastatic NSCLC with liver involvement when actionable mutations are absent.

Wu W, Guo X, Dong X et al. · Frontiers in immunology · (2026) · View on PubMed ↗ · Free PDF ↗

---

Breast cancer immunotherapy & neoadjuvant strategies

Neoadjuvant olaparib and pembrolizumab combination therapy in the treatment of patients with HRD-positive advanced ovarian cancer: A pilot study.

This pilot clinical study evaluated neoadjuvant olaparib with or without pembrolizumab in newly diagnosed HRD-positive advanced ovarian cancer patients. The key finding was the rationale-driven combination strategy targeting PARP inhibition–induced tumor immunogenicity via STING pathway activation, tested in HRD-positive FIGO stage III–IV high-grade serous or endometrioid disease using the Myriad MyChoice HRD Plus assay. If supported by outcomes, this approach could inform future trials combining PARP inhibitors and immune checkpoint blockade in HRD-positive ovarian cancer.

Harano K, Nakao T, Nishio S et al. · Clinical cancer research : an official journal of the American Association for Cancer Research · (2026) · View on PubMed ↗

Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk ERBB2-Negative Breast Cancer: The I-SPY2 Randomized Clinical Trial.

The study assessed whether dual immune checkpoint blockade with cemiplimab (anti–PD-1) plus fianlimab (anti–LAG-3) added to neoadjuvant chemotherapy improves outcomes in early-stage high-risk ERBB2-negative breast cancer in the I-SPY2 randomized platform trial. It aimed to determine efficacy of the cemiplimab/fianlimab combination in ERBB2-negative patients using the I-SPY2 serial study design with imaging and molecular analyses. This could expand neoadjuvant immunotherapy options by testing a rational dual-checkpoint strategy for a biomarker-defined breast cancer subgroup.

Isaacs C, Nanda R, Yau C et al. · JAMA oncology · (2026) · View on PubMed ↗

---

Bone health in cancer therapy (fracture risk) & osteoporosis

Post-cessation Weight Regain After Weight Management Medications: A Systematic Review and Meta-Analysis.

This systematic review and meta-analysis synthesized longitudinal evidence (from January 2020 to May 2026) on post-cessation weight regain after weight management medications, focusing on studies since incretin-based pharmacotherapy became standard of care. The key finding was that weight regain after stopping therapy remains a central barrier, with pooled estimates derived from RCT withdrawal phases and prospective/retrospective longitudinal cohorts. Clinically, the results quantify the magnitude and timing of regain risk after discontinuation, informing counseling and strategies for maintenance therapy.

Patel H, Babli SA, Shah S et al. · Cureus · (2026) · View on PubMed ↗ · Free PDF ↗

Rationale and Design of ACO-REAL: A Real-World Non-Interventional Study of Acoramidis in Routine Clinical Practice.

The ACO-REAL study design evaluated acoramidis, an oral transthyretin stabilizer, in approximately 2000 real-world adults with transthyretin amyloid cardiomyopathy (ATTR-CM; wild-type or variant) across 21 European countries. The key finding is the study’s planned prospective, non-interventional multicenter framework to generate real-world evidence on acoramidis effectiveness and safety beyond the phase 3 ATTRibute-CM trial (NCT03860935). This is scientifically and clinically significant because it will help validate whether trial benefits for ATTR-CM translate to routine practice across diverse European populations.

Fontana M, Cappelli F, Gillmore JD et al. · Cardiology and therapy · (2026) · View on PubMed ↗

Sulfated polysaccharides target RANK Lys97 to inhibit osteoclast differentiation and reverse osteoporosis.

Engineered 2-N,6-O-sulfated chitosan (26SCS), a synthetic pentasaccharide, was tested for effects on osteoclast differentiation and osteoporosis models, with mechanistic focus on the RANK receptor lysine residue Lys97 (K97). 26SCS restored bone mass and reduced bone loss by targeting RANK K97 to block RANKL signaling and osteoclast fusion while preserving preosteoclast viability to enhance PDGF-BB–driven angiogenesis-coupled osteogenesis. This provides a structure-guided, sulfate-pair–based strategy to modulate RANK signaling and vascularized bone formation, potentially offering an alternative to bisphosphonates for osteoporosis therapy.

Wang X, Ji L, Yu Y et al. · Nature biomedical engineering · (2026) · View on PubMed ↗

Adiposity Excess and Vertebral Fractures in Patients With Breast Cancer Taking Aromatase Inhibitors.

The study investigated whether adiposity excess measured as fat mass percentage (FM%) >40.8% by dual-energy X-ray absorptiometry (DXA) is associated with vertebral fracture progression in postmenopausal women with early breast cancer receiving aromatase inhibitors. It evaluated a retrospective cohort of consecutive patients (stages I–III) to test the relationship between higher FM% and vertebral fracture outcomes during AI therapy. The results could refine fracture-risk assessment beyond BMI by identifying patients with excess adiposity who may still be at elevated skeletal risk on aromatase inhibitors.

Schivardi G, Cosentini D, Scartabellati G et al. · JAMA network open · (2026) · View on PubMed ↗ · Free PDF ↗

Contemporary Real-World Treatment of Cardiac Transthyretin Amyloidosis with Tafamidis: A Long-Term Multicentre Study.

This retrospective multicentre real-world study evaluated long-term outcomes of tafamidis 61 mg in German patients with transthyretin amyloid cardiomyopathy (ATTR-CM) treated after commercial availability (April 2020 to March 2021). Most patients received tafamidis (80%), and the study assessed all-cause mortality and the composite of mortality and/or heart failure hospitalization over a median follow-up of 39 months. The results provide contemporary effectiveness and safety evidence to inform clinical decision-making for tafamidis use in routine ATTR-CM care.

Nies RJ, Ney S, Kindermann I et al. · ESC heart failure · (2026) · View on PubMed ↗ · Free PDF ↗

Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States.

This study estimated the number of cardiac deaths in US patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib versus zanubrutinib using real-world ibrutinib utilization from Symphony and head-to-head risk inputs from ALPINE (2L+) with exploratory 1L comparisons from SEQUOIA and RESONATE-2. The key finding was an estimated reduction in cardiac mortality when using zanubrutinib instead of ibrutinib, quantified via number-needed-to-treat (NNT) for incremental cardiac death risk. Clinically, the results support a potential cardiovascular safety advantage of zanubrutinib over ibrutinib for CLL patients in both first-line and later-line settings.

Brown JR, Munir T, Lipsky AH et al. · Future oncology (London, England) · (2026) · View on PubMed ↗ · Free PDF ↗

---

Shared genetic architecture in ophthalmology (myopia/exotropia)

A Shared Genetic Basis Underlying Myopia-Exotropia Comorbidity.

The study characterized the shared genetic architecture underlying the comorbidity of myopia and exotropia using large-scale GWAS data. It found a positive genetic correlation between myopia and exotropia (rg ≈ 0.25) and used cross-trait meta-analysis (MTAG), colocalization, fine mapping, and local genetic correlation plus in silico transcriptomic/regulatory annotation to prioritize shared signals. This supports a common polygenic basis for the two conditions and can guide future gene discovery and risk prediction.

Mi Y, Tao Z, Xue Z et al. · Investigative ophthalmology & visual science · (2026) · View on PubMed ↗ · Free PDF ↗

---

Perioperative pharmacology & acute kidney injury prevention

A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper.

This APASL ACLF Beijing Position Paper studied evidence-based critical care management for acute-on-chronic liver failure (ACLF) in patients with chronic liver disease, synthesizing input from a global APASL ACLF Research Consortium expert panel. It produced unified recommendations using a systematic GRADE-based consensus process to standardize ICU-level ACLF care. The guideline is clinically significant because it aims to reduce variability in management of a high-mortality syndrome by providing an actionable global framework for critical care clinicians.

Chen T, Choudhury A, Liu W et al. · Hepatology international · (2026) · View on PubMed ↗

Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial.

This retrospective, registry-based cohort study analyzed 19,498 patients from the EBMT Lymphoma Working Group who underwent haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma, comparing outcomes across the 2010–2022 period and identifying outcome predictors. The key finding was that post-transplantation outcomes changed over time and that specific clinical/transplant factors predicted survival and other endpoints. Scientifically and clinically, it provides large-scale evidence on how modern transplant practices and patient selection influence results in relapsed/refractory Hodgkin lymphoma.

Wu H, Shi W, Shi Z et al. · The Lancet. Haematology · (2026) · View on PubMed ↗

Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group.

In a multicentre, open-label, randomized phase 3 trial in haploidentical HSCT recipients, low-dose ruxolitinib (a JAK1/2 inhibitor) was used for acute GVHD prophylaxis by replacing mycophenolate mofetil within a backbone of antithymocyte globulin, a calcineurin inhibitor, and short-course methotrexate. The key finding was that ruxolitinib prophylaxis reduced acute GVHD compared with the control strategy in this haploidentical setting. This is clinically significant because it tests a targeted prophylaxis approach to improve outcomes after high-risk haploidentical transplantation.

Bazarbachi A, Fekom M, Martinez C et al. · The Lancet. Haematology · (2026) · View on PubMed ↗

Dapagliflozin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.

The study tested whether initiating dapagliflozin 1 day before elective cardiac surgery reduces postoperative acute kidney injury (AKI) at 7 days compared with placebo in a multicenter randomized clinical trial in the Netherlands. It evaluated adults undergoing elective cardiac surgery using a double-blind, placebo-controlled design. If dapagliflozin lowers AKI incidence, it would provide a practical perioperative preventive therapy to reduce a common complication after cardiac surgery.

Oosterom-Eijmael MJP, Hulst AH, de Oliveira NPM et al. · JAMA · (2026) · 1 citations · View on PubMed ↗

The Nonlinear Impact of Cumulative Fluid Balance on Severe Acute Kidney Injury During the First Three ICU Days in Sepsis.

This retrospective analysis of adult septic patients in the MIMIC-IV 3.1 database studied the nonlinear relationship between early cumulative fluid balance during the first 3 ICU days and outcomes of severe sepsis-associated acute kidney injury (SS-AKI) and 30-day mortality. The key finding was that cumulative fluid balance impacts SS-AKI risk in a nonlinear manner, quantified using restricted cubic spline (RCS) modeling and multivariable adjustment. Clinically, it supports more precise fluid management strategies in sepsis by suggesting that both magnitude and timing of fluid balance may influence kidney injury and survival.

Xi D, Yang Y, Liu S et al. · Journal of intensive care medicine · (2026) · View on PubMed ↗

Medical Management of Kidney Stones: AUA Guideline (2026) Part I: Evaluation of Patients with Kidney Stones and Dietary Management of Patients with Calcium Stones.

This AUA guideline (Part I) studied evidence-based approaches for evaluating patients with a history of kidney stones and for dietary management of calcium stone formers. It provides a structured framework derived from a systematic review to reduce recurrence risk through patient evaluation and dietary interventions. Clinically, it standardizes how clinicians assess recurrence risk and implement diet-based prevention for calcium nephrolithiasis.

Pearle MS, Matlaga BR, Antonelli JA et al. · The Journal of urology · (2026) · View on PubMed ↗

Medical Management of Kidney Stones: AUA Guideline (2026) Part II: Treatment and Follow-Up of Kidney Stones.

This AUA guideline (Part II) addressed evidence-based treatment and follow-up strategies for patients with a history of kidney stones to reduce recurrence. It synthesizes findings from a systematic review to guide ongoing management decisions after initial evaluation and treatment planning. The guideline supports consistent, risk-reducing care pathways for long-term kidney stone prevention.

Pearle MS, Matlaga BR, Antonelli JA et al. · The Journal of urology · (2026) · View on PubMed ↗

Allogeneic hematopoietic cell transplantation is curative in CARMIL2 deficiency.

This multicenter retrospective study evaluated hematopoietic cell transplantation (HCT) outcomes in patients with biallelic CARMIL2 (capping protein regulator and myosin 1 linker 2) deficiency, a disorder causing immune dysregulation and EBV+ smooth muscle tumors. Among 17 patients receiving 19 HCTs, overall survival was 82.4% with three early deaths and two patients requiring a second HCT for graft failure. Clinically, the results support HCT as a potentially curative therapy for CARMIL2 deficiency, providing outcome benchmarks for this rare genetic immune disorder.

Raedler J, Gothe F, Magg T et al. · Journal of human immunity · (2026) · View on PubMed ↗ · Free PDF ↗

---

Stem cell regeneration & muscle repair mechanisms

TRF2 couples muscle stem cell identity to regenerative repair.

The study examined the role of telomeric repeat-binding factor 2 (TRF2) in skeletal muscle stem cells (MuSCs) during injury-driven regeneration in mice. MuSC-specific TRF2 disruption worsened muscular dystrophy pathology, impaired reparative myogenesis, reduced stem cell identity maintenance, and compromised self-renewal. These findings identify TRF2 as a noncanonical regulator that couples MuSC fate-state transitions to regenerative repair, suggesting a potential molecular target for improving dystrophic muscle regeneration.

Lee JH, Nakka KK, Calhoun RP et al. · Science advances · (2026) · View on PubMed ↗

Polo/PLK1 phosphorylation relieves Centrosomin/Cnn autoinhibition to promote centrosome scaffold assembly.

This EMBO Journal study examined how Polo/PLK1 phosphorylation regulates centrosome maturation by relieving autoinhibition in the Drosophila centrosome scaffold protein Centrosomin (Cnn). It found that Cnn’s PReM domain adopts an autoinhibited helical hairpin that blocks CM2 binding, and that Polo/PLK1 phosphorylation relieves this autoinhibition to enable scaffold assembly in vivo, with phospho-blocking mutations disrupting PReM–CM2 interactions. The significance is that it clarifies a conserved regulatory logic for centrosome scaffold assembly, informing how mitotic PCM expansion is controlled across species.

Mohamad N, Wong SS, Majumdar A et al. · The EMBO journal · (2026) · View on PubMed ↗

Basement membrane turnover controls cell shape.

Using mathematical modeling and molecular dynamics simulations, this study examined how basement membrane (BM) mechanical properties regulate 3D cell shape, focusing on collagen IV network stress relaxation. The key finding was that BM stress relaxation time can control cell shape, and that collagen IV stress relaxation can be inferred from collagen IV molecule lifetimes. This is scientifically significant because it links extracellular matrix mechanics to cell morphology through measurable biophysical parameters.

Barrientos R, Meadowcroft B, Sánchez-Sánchez BJ et al. · Cell · (2026) · View on PubMed ↗

An adaptor for feedback regulation of heme biosynthesis by a mitochondrial protease.

This study examined how heme regulates negative feedback degradation of the heme biosynthetic enzyme 5-aminolevulinate synthase (ALAS) by the mitochondrial protease CLPX–CLPP (CLPXP) and identified the adaptor responsible for heme sensing. Polymerase delta-interacting protein 2 (POLDIP2) was sufficient to reconstitute heme-triggered ALAS degradation by CLPXP, was necessary for ALAS turnover in cells, and regulated heme production during erythropoiesis. These findings define a specific heme-sensing adaptor mechanism that could be leveraged to modulate heme biosynthesis in disorders of iron/porphyrin metabolism.

Cottle T, Joh L, Posner C et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗

SLC39A11 mediates intracellular manganese partitioning and adaptive iron transport.

This study investigated how the metal transporter SLC39A11 (ZIP11) controls intracellular manganese partitioning and adaptive iron transport. The authors showed that ZIP11 can remove Fe2+ from the ER/Golgi to the cytosol when ER/Golgi Fe2+ rises, and they linked ZIP11 activity to iron overload mitigation relevant to fibrosis, including AAV8-mediated ZIP11 expression that suppressed CCl4-induced liver fibrosis in mice. The work identifies SLC39A11 as a potential therapeutic target for disorders involving dysregulated iron and manganese handling.

Cui Y, Du F, Wang J et al. · Cell reports · (2026) · View on PubMed ↗

Ana1/Cep295 regulates centriole elongation via Cep135 and microtubules.

This cell biology study investigated how the centriole protein Ana1/Cep295 controls centriole elongation in relation to Cep135 and microtubules. The key finding was that Ana1 promotes centriole elongation via two mechanisms: direct interaction with Cep135 to recruit it to proximal centriole-like structures and microtubule binding/bundling activity that is required for elongation in vivo. Scientifically, it clarifies the molecular pathway linking Ana1/Cep295 to Cep135 and microtubule dynamics, advancing understanding of centriole biogenesis and centrosome function.

Wang Z, Qian Y, Wang X et al. · The Journal of cell biology · (2026) · View on PubMed ↗ · Free PDF ↗

The titin N2A-MARP signalosome constrains muscle longitudinal hypertrophy in response to stretch.

The study investigated how the titin N2A–MARPs signalosome constrains muscle longitudinal hypertrophy in response to stretch, using unilateral diaphragm denervation (UDD) in rats and mice to model titin-stiffness-dependent stretch effects. Using global transcriptomic and proteomic analyses after UDD versus bilateral diaphragm denervation (BDD), the authors identified titin-associated signaling changes that distinguish stretch-induced remodeling from denervation effects. These results define a mechanistic pathway linking titin mechanosensing to muscle growth control, informing targets for preventing maladaptive hypertrophy.

van der Pijl R, Gohlke J, Strom J et al. · eLife · (2026) · View on PubMed ↗ · Free PDF ↗

Targeting chaperone-mediated autophagy by nutritional interventions mitigates age-related cardiac fibrosis and diastolic dysfunction.

This study examined how nutritional interventions modulating chaperone-mediated autophagy (CMA) affect age-related cardiac fibrosis and diastolic dysfunction in aging hearts and cardiac fibroblasts, focusing on the CMA substrate SHMT2. CMA was suppressed with aging, promoting collagen overproduction, while enhancing CMA activity ameliorated fibrosis and diastolic dysfunction and implicated SHMT2 accumulation as a driver of increased collagen synthesis. These findings suggest CMA-targeted nutritional strategies could be a therapeutic approach to reduce cardiac remodeling and heart failure risk in the elderly by correcting SHMT2-linked collagen production.

Wang Z, Zhang Z, Ping Z et al. · Autophagy · (2026) · View on PubMed ↗

Inactivation of V-ATPase induces autophagy and ectopic Notch activation to promote intestinal stem cell differentiation in adult drosophila midgut.

This study used a large-scale RNAi screen in adult Drosophila intestinal stem cells (ISCs) to test the role of V-ATPase subunits, particularly Vha68-2/ATP6V1A, in ISC proliferation and differentiation and how this links to autophagy and Notch signaling. Inactivation of Vha68-2 induced autophagy with accumulation of plasma membrane-derived structures in autophagosomes/lysosomes and promoted ectopic Notch activation to drive ISC differentiation and tissue regeneration. Scientifically, it identifies V-ATPase as a regulator of autophagy–Notch crosstalk in adult stem cell maintenance, offering a mechanistic framework for how lysosomal/autophagic control influences regenerative fate decisions.

Li Z, Zhao H, Zhang D et al. · Autophagy · (2026) · View on PubMed ↗

---

Adolescent surgical techniques for hernia

Mesh-free laparoscopic inguinal sac resection in adolescents: multicenter outcomes of a sac-resection approach for indirect inguinal hernia.

This multicenter retrospective study evaluated feasibility and early-to-midterm outcomes of mesh-free laparoscopic inguinal sac resection (LISAR) in adolescents aged 12–18 years with indirect inguinal hernia. LISAR was performed without mesh placement and without routine internal ring closure, aiming to reduce complications while maintaining effective hernia management. The results support LISAR as a potentially safe, sac-oriented alternative to mesh-based approaches in adolescent indirect hernia care, though longer-term comparative evidence is needed.

Riquelme M, Cendejas-Higuera A, Cantu-Zendejas A et al. · Hernia : the journal of hernias and abdominal wall surgery · (2026) · View on PubMed ↗

---

Hypertension pharmacology (aldosterone synthase inhibitors)

Efficacy and Safety of Selective Aldosterone Synthase Inhibitors in Uncontrolled Hypertension: A Systematic Review and Dose-Specific Network Meta-Analysis of Randomized Controlled Trials.

This systematic review and dose-specific network meta-analysis synthesized randomized controlled trials of selective aldosterone synthase inhibitors—baxdrostat and lorundrostat—versus placebo for uncontrolled hypertension. Across 16 efficacy and safety outcomes, the analysis assessed dose-level effects on blood pressure and hyperkalemia/cortisol-sparing safety using trial sequential analysis and GRADE-CINeMA certainty ratings. The work clarifies the comparative efficacy and safety profile of CYP11B2-selective agents in resistant/uncontrolled hypertension, informing dose selection and clinical trial interpretation for newer ASIs.

Hammad N, Elkasaby MH, Gadelmawla AF et al. · Cardiology in review · (2026) · View on PubMed ↗

Complementary body weight and cardiometabolic benefits of higher GLP-1 and lower GIP: Genetic evidence from large-scale phenomic analyses.

This study used tree-structured phenotypic modeling (TreeWAS) and factorial Mendelian randomization to test whether genetically higher GLP-1 and lower GIP (via human genetic instruments) associate with complementary cardiometabolic benefits. The key finding was that higher GLP-1–related signaling and lower GIP–related signaling show distinct, complementary associations with improved cardiometabolic outcomes, informing the debate on whether GIP agonism versus antagonism should be pursued. Scientifically, it supports a rationale for therapeutic strategies that enhance GLP-1 while lowering GIP, potentially guiding future drug development and safety expectations.

Wang L, Jiang F, Yuan S et al. · Metabolism: clinical and experimental · (2026) · View on PubMed ↗

---

Orthopedic diagnostics & joint arthroscopy/arthroplasty outcomes

Needle arthroscopy as an emerging office-based tool: Promising diagnostic value but limited evidence for therapeutic equivalence-A systematic review and frequentist meta-analysis.

This systematic review and frequentist meta-analysis compared needle (nano) arthroscopy with conventional arthroscopy for diagnostic performance, functional outcomes, and complication rates. The key finding was that needle arthroscopy shows promising diagnostic value, but evidence remains limited regarding therapeutic equivalence and safety compared with conventional arthroscopy. Clinically, this supports needle arthroscopy as an emerging office-based diagnostic tool while highlighting the need for higher-quality comparative trials for therapeutic indications.

Banke IJ, Becker R, Voss M et al. · Journal of experimental orthopaedics · (2026) · View on PubMed ↗

Early recovery patterns differ between medially congruent and posterior-stabilized total knee arthroplasty, with comparable 2-year outcomes: A triple-blinded randomized clinical trial.

This triple-blinded randomized clinical trial compared early recovery trajectories and 2-year outcomes between Persona® medially congruent (MC) and posterior-stabilized (PS) total knee arthroplasty in 82 patients with primary Kellgren-Lawrence grade IV osteoarthritis. The study found that early recovery patterns differed between MC and PS designs, while 2-year outcomes were comparable between groups. These results suggest that implant geometry may influence short-term functional recovery without clear long-term outcome differences at two years.

Vosoughi F, Vaziri AS, Khashami F et al. · Journal of experimental orthopaedics · (2026) · View on PubMed ↗

Molecular Advances in Intra-Articular Injections for Knee Osteoarthritis.

This narrative review summarized molecular advances relevant to intra-articular injection therapies for knee osteoarthritis (KOA), focusing on how these treatments may modulate inflammatory and cartilage-related pathways. It highlights that corticosteroid injections can provide short-term pain relief by suppressing inflammatory activity, while other emerging intra-articular approaches are discussed in terms of their proposed mechanisms. By consolidating mechanistic evidence, the review supports more rational selection and development of injection-based strategies for KOA.

Roman-Belmonte JM, De la Corte-Rodriguez H, Rodriguez-Merchan EC · Frontiers in bioscience (Landmark edition) · (2026) · View on PubMed ↗ · Free PDF ↗

---

Neurodegeneration & traumatic brain injury epidemiology

Neurodegenerative mortality among National Football League Players.

This population-based retrospective cohort study assessed neurodegenerative mortality among National Football League (NFL) players with varying exposure to repetitive head impacts (RHI) in a fully enumerated cohort of all players who debuted between 1960 and 2019 and played at least one NFL game. The key finding was an association between RHI exposure and neurodegenerative mortality while addressing prior biases such as selection bias and retrospective subjective diagnoses. Scientifically, it strengthens evidence linking head-impact exposure in professional football to later neurodegenerative outcomes and supports improved exposure-risk assessment.

Luster CB, Abdolmohammadi B, Mastrodicasa MJ et al. · EClinicalMedicine · (2026) · View on PubMed ↗ · Free PDF ↗

Impact of brain frailty on language recovery in patients with acute post-stroke aphasia: a post-hoc analysis of the LEXI randomized controlled trial.

This post-hoc analysis of the LEXI multicenter randomized controlled trial investigated whether brain frailty components influence language recovery after acute post-stroke aphasia and whether frailty modifies the dose-dependent effect of speech and language therapy (SLT). Patients were randomized to tablet-assisted SLT using the Neolexon application versus standard SLT, and the analysis related frailty measures to language outcomes. The results clarify which frailty features may predict poorer recovery and whether SLT intensity benefits differ by frailty status, supporting more personalized rehabilitation planning.

Wischmann J, Forbrig R, Franzen J et al. · Neurological research and practice · (2026) · View on PubMed ↗

Light-activated tetanus neurotoxin for conditional proteolysis and inducible synaptic inhibition in vivo.

This Nature Methods study engineered a light-activated tetanus neurotoxin (LATeNT) by inserting the LOV light-sensitive domain into the tetanus neurotoxin light chain to enable conditional proteolysis of VAMP2 in vivo. The key finding is that LATeNT is inactive in the dark but, after 10–20 minutes of weak blue-light exposure, potently inhibits synaptic transmission across multiple brain regions and long-range axonal projections with reversibility. This is clinically and scientifically significant because it provides an optogenetic-like, protease-based tool for spatiotemporally precise, inducible synaptic inhibition in living brains.

Roh H, Kim D, Kim B et al. · Nature methods · (2026) · View on PubMed ↗

Single-cell spatial mapping of human kidney development implicates the microenvironment in guiding cell fate decisions.

This study mapped human kidney development by integrating single-cell RNA sequencing with spatial transcriptomics across more than 700,000 cells to infer how the microenvironment shapes cell fate decisions. The key finding is that spatial gene-expression patterns and differentiation trajectories reveal previously unrecognized plasticity, where early-established fate can be altered later in development. This is significant because it provides a human, spatially resolved framework for understanding how niche signals coordinate organogenesis and cell fate transitions.

Levinsohn J, Grindel S, Dumoulin B et al. · Nature genetics · (2026) · View on PubMed ↗

Cold exposure aggravates vein occlusion through non-shivering thermogenesis-induced thrombocytopoiesis.

This Cell Research study examined how cold exposure affects vein occlusion (VO), including deep venous thrombosis (DVT) and retinal vein occlusion (RVO), using mouse models. It found that cold exposure increases peripheral platelet counts through non-shivering thermogenesis–driven adipose thermogenesis and elevated circulating free fatty acids (FFAs), which then promote thrombocytopoiesis and aggravate VO. The significance is that it mechanistically connects seasonal cold exposure to thrombotic risk, highlighting metabolic pathways (FFA/β-oxidation) as potential intervention points.

Xie S, Chen K, Sun X et al. · Cell research · (2026) · View on PubMed ↗

Losartan and prednisolone for post-COVID syndrome and cardiac inflammation: a randomized, double-blind, placebo-controlled trial.

In a randomized, double-blind, placebo-controlled multicenter trial, losartan plus prednisolone was tested in 279 participants with post-COVID syndrome and inflammatory cardiac involvement defined by cardiovascular magnetic resonance. The primary endpoint—change in left ventricular ejection fraction—was neutral, with no meaningful between-group difference versus placebo over 16 weeks. Clinically, the trial suggests that targeting endothelial dysfunction/low-grade inflammation with losartan and corticosteroids may not improve LV systolic function in this population, informing future therapeutic direction for post-COVID cardiac inflammation.

Puntmann VO, Nagel E, Beitzke D et al. · Nature communications · (2026) · View on PubMed ↗

Cerebrospinal fluid biomarkers reveal transdiagnostic synaptic dysfunction across major psychiatric disorders.

The study quantified cerebrospinal fluid (CSF) synaptic proteins across major psychiatric disorders to identify transdiagnostic biomarkers, analyzing CSF from 672 individuals with anorexia nervosa, ADHD, bipolar disorder, schizophrenia spectrum disorders, and healthy controls using targeted mass spectrometry. Synaptic protein levels were markedly reduced in schizophrenia spectrum disorders with intermediate reductions in bipolar disorder and ADHD, and data-driven modeling identified shared biomarker contrasts related to psychotic experience and cognitive/functional impairment. This supports CSF synaptic dysfunction as an in vivo, transdiagnostic feature and provides candidate biomarker pairs for stratifying psychiatric illness biology.

Göteson A, Nilsson J, Camporesi E et al. · Nature communications · (2026) · View on PubMed ↗ · Free PDF ↗

Reappraising lithium, triiodothyronine and second-generation antipsychotic augmentation treatment for major depression: a systematic review and meta-analysis with bias-adjustment analyses.

This systematic review and meta-analysis with bias-adjustment analyses reappraised pharmacological augmentation for major depressive disorder (MDD) in adults, focusing on lithium, second-generation antipsychotics (SGAs), and triiodothyronine (T3) using placebo-controlled randomized controlled trials. It evaluated the robustness of evidence for augmentation efficacy by synthesizing response outcomes across included studies while accounting for bias. The findings are intended to clarify which augmentation strategies have reliable benefit for treatment-resistant or inadequately responding MDD patients.

Hsu TW, Hsu CW, Thompson T et al. · BMJ mental health · (2026) · View on PubMed ↗

A cortical-hypothalamic neural circuit for compulsive eating in mice.

This study examined a cortical–hypothalamic circuit for compulsive eating in mice using a binge-eating-induced compulsive eating (BiCOM) paradigm and circuit manipulation of rostral zona incerta GABAergic neurons (rZIGABA) and their medial prefrontal cortex (mPFC) inputs. rZIGABA neurons drove compulsive eating, and bidirectional manipulation of either rZIGABA activity or mPFC→rZIGABA inputs modulated compulsive eating behavior. These findings identify a specific mPFC–hypothalamic GABAergic node as a mechanistic target for compulsive binge-eating biology relevant to BED/obesity.

Leow YN, Senol E, Qian X et al. · Neuron · (2026) · View on PubMed ↗

Atlas of lysosomal aging reveals a metabolite signature shared with lysosomal storage disorders.

This Science study used rapid lysosomal isolation to build a multitissue atlas of lysosomal metabolite changes during aging and compared them with lysosomal storage disorder signatures. Aged lysosomes in brain, heart, muscle, and white adipose tissue accumulated glycerophosphodiesters and cystine in a way that increased linearly with age and preceded organismal decline, and these metabolites are causally linked to Batten disease and cystinosis. The work is significant because it connects lysosomal storage disorder pathways to aging and shows that caloric restriction mitigates some (heart/muscle) but not all (brain) lysosomal aging signatures.

Puszynska AM, Nguyen TP, Cangelosi AL et al. · Science (New York, N.Y.) · (2026) · View on PubMed ↗

Assessing the effects of virtual reality-based positive psychotherapy on emotion, life satisfaction, and suicidal ideation in major depression: A mixed-methods randomized controlled trial.

This mixed-methods randomized controlled trial studied whether virtual reality (VR)-based positive psychotherapy (PPT) improves emotion, life satisfaction, and suicidal ideation in people with major depressive disorder (MDD). The intervention group received VR-based PPT (n=39) versus a control condition (n=39), and the study assessed changes in the targeted psychological outcomes alongside qualitative components. The results could support VR-delivered PPT as a scalable adjunctive approach for reducing suicidal ideation in MDD.

Hosseini FA, Bahman K, Shaygan M et al. · PloS one · (2026) · View on PubMed ↗

X-linked SYTL4 missense variant disrupts RAB27A-dependent vesicle trafficking and synaptic transmission in autism.

This genetic study identified an X-linked autism spectrum disorder mechanism involving a SYTL4 missense variant. The authors found a recurrent hemizygous SYTL4 R126H variant in four unrelated male individuals, located in the Rab-binding domain of SYTL4, and showed that SYTL4 functions as a RAB27A effector regulating presynaptic vesicle trafficking and synaptic transmission in the mammalian brain. These results connect disrupted RAB27A-dependent synaptic vesicle trafficking to ASD pathogenesis and highlight SYTL4 as a candidate causal gene.

Liao Y, Zhang S, Zhang X et al. · Proceedings of the National Academy of Sciences of the United States of America · (2026) · View on PubMed ↗

Nicotine E-Cigarettes for Cigarette Smoking Cessation: Recommendations to US-Based Clinicians.

This Special Communication evaluated evidence and provided recommendations for US-based clinicians on using nicotine e-cigarettes for cigarette smoking cessation in people with nicotine dependence. The key finding is that nicotine e-cigarettes are less harmful than cigarettes and have shown greater cessation effectiveness than FDA-approved nicotine replacement therapies, while clinician misperceptions about e-cigarette harms remain common. Clinically, it supports guideline-consistent counseling and prescribing approaches that may improve quit rates by addressing nicotine dependence with a lower-harm nicotine delivery product.

Leavens ELS, Pebley K, Smith TT et al. · JAMA · (2026) · 1 citations · View on PubMed ↗

Integrative Analysis Reveals Interactions Between Gut Microbiota-Derived Metabolites and the Brain in Parkinson’s Disease.

This integrative computational and experimental study investigated Parkinson’s disease (PD) by linking gut microbiota-derived metabolites to brain host genes using database-derived microbial/metabolite inputs and PD brain transcriptomic data. The key finding was the identification of candidate gut microbial metabolites and host genes whose predicted protein targets intersect with differentially expressed genes in PD brain tissue, implicating a gut–brain metabolic mechanism. The scientific significance is that it generates testable targets for understanding how microbiome metabolites may contribute to PD pathobiology and for developing metabolite- or gene-directed interventions.

Shao Y, Han J, Hu S · Molecular neurobiology · (2026) · View on PubMed ↗

Neurotrophic Factors in Stroke, Traumatic Brain Injury, and Neurodegeneration: A Convergent Pathophysiological and Translational Perspective.

This integrative translational perspective reviewed neurotrophic factors (NTFs)—including NGF, BDNF, NT-3, GDNF, CNTF, and VEGF—in stroke, traumatic brain injury (TBI), and neurodegeneration such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). It argues that despite different triggers and timelines, these conditions converge on shared pathophysiological phenotypes involving excitotoxicity, oxidative stress, and mitochondrial dysfunction, with NTFs contributing to neuronal survival and plasticity. The synthesis supports NTF-centered strategies as potential translational targets for improving outcomes across multiple neurological disorders.

Shcheblykina OV, Kostina DA, Pokrovskii MV et al. · Journal of integrative neuroscience · (2026) · View on PubMed ↗ · Free PDF ↗

Advances in biomarkers for Parkinson’s disease: from molecular pathology to precision diagnostics.

This review summarized advances in Parkinson’s disease biomarkers, emphasizing the shift from static measurements to functional activity detection and focusing on precision diagnostics. It highlights the α-synuclein seed amplification assay (α-Syn-SAA) as an ultrasensitive and specific method for detecting pathological α-synuclein seeds in clinical and prodromal stages. These developments are significant for earlier diagnosis, improved subtyping, and better prognosis to enable precision interventions in PD.

Li X, Chen H, Wang X et al. · Journal of Zhejiang University. Science. B · (2026) · View on PubMed ↗

---

---

Generated automatically on August 01, 2026 from PubMed’s trending articles. Summaries are AI-generated; always consult the original publication for clinical or research decisions.